• RobotToaster@mander.xyzOP
    link
    fedilink
    arrow-up
    1
    ·
    2 months ago

    I agree, but I don’t think medicine is a good model to follow. There’s a lot of criticism for how slow and inflexible drug approvals are because of all the bureaucracy.

    • Chuymatt@beehaw.org
      link
      fedilink
      arrow-up
      1
      ·
      edit-2
      2 months ago

      It is slow because there needs to be enough data to show enough of a benefit with a low enough risk to be given approval.

      • RobotToaster@mander.xyzOP
        link
        fedilink
        arrow-up
        1
        ·
        2 months ago

        The problem is that even with drugs that are proven safe, and almost certainly effective, often that proof doesn’t meet the arbitrary standards of regulators. NICE refusing to approve ketamine therapy for depression is one I’m specifically aware of, as I suffer from treatment resistant depression.

        • Chuymatt@beehaw.org
          link
          fedilink
          arrow-up
          1
          ·
          2 months ago

          Was it ketamine or was it MDMA? I know that the studies for MDMA were flawed and bit and did not meet muster.

          Is there an issue with bias? Always. We are dealing with humans. But I know that if the pharm companies get to have them all approved we’d be in trouble.

          If you are in Most states, you can have treatment with ketamine. ~190 a month, last I checked.

          Covered by insurance, nope.